Clinical Trial Update: Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF) [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial evaluating the regenerative capacity of CardioCell in chronic ischemic heart failure has completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CardioCell

Snippet

Sponsor: John Paul II Hospital, Krakow | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED